Skip to main content
Log in

A Method for Assay of Losartan, Its Active Metabolite E-3174, and Glibenclamide in Human Serum and Urine by HPLC-MS/MS

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

A simple, rapid, and reliable method for simultaneous assay of losartan, its active metabolite E-3174, and glibenclamide was developed and validated. The method is universal and allows metabolites to be assayed in both serum and urea. Application of the method for determination of the activity of isoenzyme CYP2C9 with simultaneous monitoring of glibenclamide conditions was demonstrated. The method was shown to be specific for assay of study compounds in patients simultaneously taking multiple drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13

Similar content being viewed by others

References

  1. M. Zoppi, S. Braunschweig, U. P. Kuenzi, et al., Eur. J. Clin. Pharmacol., 56(5), 427 – 430 (2000).

    Article  CAS  PubMed  Google Scholar 

  2. J. Kirchheiner, J. Brockmöller, I. Meineke, et al., Clin. Pharmacol. Ther., 71(4), 286 – 296 (2002).

    Article  CAS  PubMed  Google Scholar 

  3. A. Surendiran, S. C. Pradhan, A. Agrawal, et al., Eur. J. Clin. Pharmacol., 67(8), 797 – 801 (2011).

    Article  CAS  PubMed  Google Scholar 

  4. Z. Li, G. Wang, L. S. Wang, et al., Xenobiotica, 39(10), 788 – 793 (2009).

    Article  CAS  PubMed  Google Scholar 

  5. A. Petsalo, M. Turpeinen, O. Pelkonen, et al., J. Chromatogr. A, 1215(1 – 2), 107 – 115 (2008).

  6. P. Dorado, E. Machín, F. de Andrés, et al., Drug Metab. Drug Interact., 27(4), 217 – 223 (2012).

    Article  CAS  Google Scholar 

  7. F. De Andrés, M. Sosa-Macías, and A. Lerena, Bioanalysis, 6(5), 683 – 696 (2014).

    Article  PubMed  Google Scholar 

  8. Ü. Yasar, C. Forslund-Bergengren, G. Tybring, et al., Clin. Pharmacol. Ther., 71(1), 89 – 98 (2002).

    Article  CAS  PubMed  Google Scholar 

  9. S. Tanaka, S. Uchida, N. Inui, et al., Biol. Pharm. Bull., 37(1), 18 – 25 (2014).

    Article  CAS  PubMed  Google Scholar 

  10. G. Sartor, A. Melander, B. Schersten, et al., Diabetologia, 18(1), 17–22 (1980).

    Article  CAS  PubMed  Google Scholar 

  11. L. A. Sánchez-Nava, U. Bautista-Sánchez, A. L. Robles-Piedras, GSC Biol. Pharmaceut. Sci., 7(01), 96 – 101 (2019).

    Article  Google Scholar 

  12. G. I. Gorodetskaya, E. V. Shikh, M. V. Zhuravleva, et al., Ved. Nauchn. Tsentr. Éksper. Sredstv. Med. Primen., 7(4), 199 – 211 (2017).

    Google Scholar 

  13. I. E. Shokhin, G. V. Ramenskaya, G. F. Vasilenko, et al., Vopr. Biol. Med. Farm. Khim., 7(6), 36 – 38 (2009).

    Google Scholar 

  14. C. Hess, F. Musshoff, and B. Madea, Anal. Bioanal. Chem., 400(1), 33 – 41 (2011).

    Article  CAS  PubMed  Google Scholar 

  15. K. S. Lakshmi and T. Rajesh, ISRN Pharmaceutics, 2011 (2011).

  16. T. M. Binz, N. Villani, H. Neels, et al., Forensic Sci. Int., 223(1–3), 119 – 124 (2012).

    Article  CAS  PubMed  Google Scholar 

  17. X. Zhang, X. Wang, D. I. Vernikovskaya, et al., Biomed. Chromatogr., 29(4), 560 – 569 (2015).

    Article  CAS  PubMed  Google Scholar 

  18. H. J. Shah, M. L. Kundlik, N. K. Patel, et al., J. Sep. Sci., 32(20), 3388 – 3394 (2009).

    Article  CAS  PubMed  Google Scholar 

  19. B. Prasaja, L. Sasongko, Y. Harahap, et al., J. Pharmaceut. Biomed., 49(3), 862 – 867 (2009).

    Article  CAS  Google Scholar 

  20. M. Polinko, K. Riffel, H. Song, et al., J. Pharmaceut. Biomed., 33(1), 73 – 84 (2003).

    Article  CAS  Google Scholar 

  21. T. Iwasa, T. Takano, K. I. Hara, et al., J. Chromatogr. B, 734(2), 325 – 330 (1999).

    Article  CAS  Google Scholar 

  22. R. A. Stearns, P. K. Chakravarty, R. Chen, et al., Drug Metab. Dispos., 23(2), 207 – 215 (1995).

    CAS  PubMed  Google Scholar 

  23. P. A. Shah, P. Sharma, J. V. Shah, et al., Turk. J. Chem., 39(4), 714 – 733 (2015).

    Article  CAS  Google Scholar 

  24. C. Krämer, J. Sunkomat, J. Witte, et al., Circ. Res., 90(7), 770 – 776 (2002).

    Article  PubMed  Google Scholar 

  25. C. I. Furtek and M. W. Lo, J. Chromatogr. B, 573(2), 295 – 301 (1992).

    Article  CAS  Google Scholar 

  26. T. Rydberg, A. Jönsson, and A. Melander, J. Clin. Pharm. Ther., 20(5), 283 – 295 (1995).

    Article  CAS  PubMed  Google Scholar 

  27. I. Niopas and A. C. Daftsios, J. Pharmaceut. Biomed., 28(3–4), 653 – 657 (2002).

    Article  CAS  Google Scholar 

  28. A. N. Mironov (ed.), Guidelines for Expert Assessment of Medicines [in Russian], Grif i. K, Moscow (2013), Vol. 1, pp. 201 – 207.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. I. Gorodetskaya.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 56, No. 1, pp. 52 – 59, January, 2022.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gorodetskaya, G.I., Bunyatyan, N.D., Mel’nikov, E.S. et al. A Method for Assay of Losartan, Its Active Metabolite E-3174, and Glibenclamide in Human Serum and Urine by HPLC-MS/MS. Pharm Chem J 56, 118–125 (2022). https://doi.org/10.1007/s11094-022-02612-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-022-02612-3

Keyword

Navigation